formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with maraviroc in 1 studies
| Studies (formylmethionyl-leucyl-phenylalanine methyl ester) | Trials (formylmethionyl-leucyl-phenylalanine methyl ester) | Recent Studies (post-2010) (formylmethionyl-leucyl-phenylalanine methyl ester) | Studies (maraviroc) | Trials (maraviroc) | Recent Studies (post-2010) (maraviroc) |
|---|---|---|---|---|---|
| 67 | 1 | 6 | 785 | 124 | 539 |
| Protein | Taxonomy | formylmethionyl-leucyl-phenylalanine methyl ester (IC50) | maraviroc (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 3.1 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0014 | |
| C-C chemokine receptor type 5 | Homo sapiens (human) | 0.0044 | |
| C-C chemokine receptor type 5 | Mus musculus (house mouse) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Rosa, A; Lichtner, M; Massetti, AP; Mastroianni, CM; Mengoni, F; Rossi, R; Sauzullo, I; Vullo, V | 1 |
1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and maraviroc
| Article | Year |
|---|---|
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells.
Topics: CCR5 Receptor Antagonists; Chemokine CCL2; Chemokine CCL4; Chemokine CCL5; Chemotaxis; Chemotaxis, Leukocyte; Cyclohexanes; Dendritic Cells; HIV Fusion Inhibitors; HIV Infections; Humans; Macrophages; Maraviroc; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Receptors, CCR5; Triazoles | 2011 |